Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5631 Journals
4466 Congresses
10000+ Unique Records

Experimental & Molecular Medicine


Title Abbreviation
Exp Mol Med
ISSN
2092-6413
Electronic ISSN
1226-3613
Readership
Academics, Biologists, Biomedical Researchers, Cardiologists, Cell Biologists, Cytologists, Medicinal Chemists, Molecular Biologists, Neurologists, Neuroscientists, Physiologists, Researchers
Scope
Experimental & Molecular Medicine (EMM) is Korea's first biochemistry journal (founded in 1964) and is relaunched in 1996 as an Open Access, fully peer-reviewed international journal. It is a medical research journal devoted to publishing the latest developments in translational research and the recent discoveries in the biomedical field. Submission is encouraged of papers that involve genetic, molecular and cellular studies of human physiology and diseases. The journal seeks to highlight the improved clinical benefits for human health from experimental and translational research performed using specific molecular tools. Studies that encompass basic discoveries with clinical relevance as well as articles dealing with clear in vivo relevance and novelty will also be welcomed. Experimental & Molecular Medicine is an open access, online-only journal. Journal Information On this page: Aims & scope of journal | Citing articles in Experimental & Molecular Medicine | Article and journal metrics | Funding Why Publish in Experimental & Molecular Medicine? Focuses on latest developments & discoveries in translational & biomedical research fields. Welcomes papers dealing with clear in vivo relevance and novelty, and basic discoveries. Open access publication ensures that your work is easily discovered, accessed and shared. Aims and scope of journal Experimental & Molecular Medicine (EMM) is Korea's first biochemistry journal (founded in 1964) and is relaunched in 1996 as an Open Access, fully peer-reviewed international journal. It is a medical research journal devoted to publishing the latest developments in translational research and the recent discoveries in the biomedical field. Submission is encouraged of papers that involve genetic, molecular and cellular studies of human physiology and diseases. The journal seeks to highlight the improved clinical benefits for human health from experimental and translational research performed using specific molecular tools. Studies that encompass basic discoveries with clinical relevance as well as articles dealing with clear in vivo relevance and novelty will also be welcomed. Experimental & Molecular Medicine is an open access, online-only journal. Topics of particular interest within the journal's scope include, but are not limited to, those listed below: Cancer biology, Immunology, Neuroscience, Cardiovascular biology, Genetics and genomics, Gene therapy, Metabolic diseases, Stem cells and regenerative medicine, Physiology and diseases, Molecular Medicine. The journal publishes peer-reviewed Original Articles and Reviews. In addition, Research Summaries are provided for selected articles. Editorial articles are brief comments written by the editor(s) of the journal or by guest editor(s) of Special Features based on the contents of the current issue or topical subjects that fall within the scope of the journal.
Sponsoring Association(s)
Korean Federation of Science and Technology Societies (KOFST)
Publisher Name
Springer Nature
To see more details about Experimental & Molecular Medicine, Subscribe Now!
Impact Factor Electronic Circulation Submission to Acceptance Acceptance to Online Publication Rejection Rate Frequency Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
 
– Kait G
Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
– Michael K.
Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
- Weill Cornell Medical Library